Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.040
-0.060 (-5.45%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Estrella Immunopharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$8.00
Upside
+669.23%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +669.23% | Feb 9, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 → $8 | Strong Buy | Maintains | $16 → $8 | +669.23% | Jan 28, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +1,438.46% | Nov 3, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +1,438.46% | Aug 12, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +1,438.46% | Jun 3, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +1,438.46% | May 29, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +1,438.46% | Feb 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +1,438.46% | Feb 18, 2025 |